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Abstract
Objective. The objective of this study was to analyse an association between nailfold capillary abnorm-
alities and the presence and severity of erectile dysfunction (ED) in men with SSc.
Methods. A cross-sectional analysis of the prospective European League Against Rheumatism (EULAR)
Scleroderma Trial and Research database was performed. Men with SSc were included if they had
undergone nailfold capillaroscopy and simultaneous ED assessment with the 5-item International Index
for Erectile Function (IIEF-5).
Results. Eighty-six men met the inclusion criteria. Eight men (9.3%) had not had sexual intercourse and
could not be assigned an IIEF-5 score. Sixty-nine of the 78 men (88.5%) with an IIEF-5 score had nailfold
capillary abnormalities, of whom 54 (78.3%) suffered from ED. Nine men (11.5%) had no nailfold capillary
abnormalities, of whom six (66.7%) had ED (P= 0.44). ED was more frequent in older men (P= 0.002) and
in men with diffuse disease (P= 0.06). Men with abnormal capillaroscopy had a higher median EULAR
disease activity than men without (P= 0.02), a lower diffusing capacity of the lung (P= 0.001) and a higher
modified Rodnan skin score (P= 0.04), but mean IIEF-5 scores did not differ [15.7 (S.D. 6.2) vs 15.7 (S.D.
6.3)]. IIEF-5 scores did not differ between men with early (n= 12), active (n= 27) or late (n= 27) patterns
(IIEF-5 scores of 17.9, 16.3 and 14.7, respectively). There were no differences in the prevalence of early,
active and late capillaroscopy patterns between men with or without ED.
Conclusion. Neither the presence or absence of abnormal capillaroscopy findings nor the subdivision into
early, active and late patterns is associated with coexistent ED in SSc.
Key words: systemic sclerosis, nailfold capillaroscopy, scleroderma pattern, erectile dysfunction, pathogenesis,
vasculopathy, ageing.
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Introduction
Patients with SSc frequently have clinical complications of
vascular damage such as RP, digital ulcers, renal crisis,
pulmonary arterial hypertension and abnormal nailfold
capillaries [1, 2]. After an average of 3 years of disease
duration, 80% of men with SSc also suffer from erectile
dysfunction (ED) [3, 4]. The pathogenesis of ED in SSc
involves collagen deposition and fibrosis in the corpus
cavernosum [5] and therefore clearly differs from the
macroangiopathy observed in atherosclerosis. It is un-
clear, however, if microvascular damage may precede or
even parallel the fibrotic changes in penile tissue that
ultimately account for ED.
Small vessels can be visualized by nailfold capillaro-
scopy. In SSc, nailfold findings are typically classified
into normal, early, active and late scleroderma patterns
[2, 6]. Nailfold abnormalities and patterns derived from
them are associated with circulating markers of vascular
disease [7], significantly and gradually increase during
SSc progression [6] and have been demonstrated to
predict future vascular complications, such as severe
cutaneous and pulmonary involvement [811].
While ED in SSc has already been addressed in a pre-
vious paper [4], we aimed to gain insights about a possible
contribution of microvascular damage to the ED observed
in SSc patients, and therefore we asked if there is a link
between nailfold capillary abnormalities and the presence
or severity of ED. To address this issue we analysed the
database of the European League Against Rheumatism
(EULAR) Scleroderma Trial and Research (EUSTAR)
group.
Methods
The multinational EUSTAR database was inaugurated in
2004. Participating centres are required to have local
ethics committee approval; patients must provide in-
formed written consent prior to entry and fulfil the ACR
classification criteria for SSc [12]. For the purpose of this
study, the EUSTAR electronic data entry system, which
prospectively follows patients in yearly visits, was
amended by a separate data form with items specific to
the ED study. Men with SSc were included in this analysis
if they had undergone nailfold capillaroscopy and were
simultaneously administered the 5-item International
Index for Erectile Function (IIEF-5) questionnaire, an
index of ED severity that is validated in several languages,
has high retest reliability and is sensitive and specific for
detecting treatment-related changes [13]. The IIEF-5 pro-
vides a numerical score that is classified into five cate-
gories of ED severity: severe (score 57), moderate (score
811), mild to moderate (score 1216), mild (score 1721)
and no ED (score 2225) [13]. Nailfold findings were ana-
lysed on eight fingers and the pathologies were classified
into normal, early, active or late scleroderma patterns [6].
In case of multiple annual datasets, we analysed the last
visit.
Statistical analysis was carried out using Stata (version
11.2; StataCorp, College Station, TX, USA) by analysing
SSc presentations for associations between ED, nailfold
capillary abnormalities and other clinical features of ED.
The dataset was analysed using chi-square and Fisher’s
tests, t-tests, analysis of variance (ANOVA), Wilcoxon and
KruskalWallis tests, as appropriate. Continuous data are
presented as mean (S.D.) or median with interquartile
range (IQR), as appropriate, while binary parameters are
presented as percentages.
Results
Eighty-six men had undergone nailfold capillaroscopy and
were simultaneously administered the IIEF-5 question-
naire and therefore met the inclusion criteria. Of these,
eight men (9.3%) had not had sexual intercourse in the
last 6 months and could therefore not be assigned an IIEF-
5 score. These were excluded from the analysis. In three
men with abnormal capillaroscopy, the exact pattern
(early, active or late) was not specified.
We first analysed SSc disease characteristics accord-
ing to the presence or absence of ED and additionally by
categorizing men by ED severity (Table 1). Although more
patients suffering from ED had a late scleroderma pattern
(47.1%) than patients without ED (20%, P= 0.06), there
was no difference in the prevalence of a late scleroderma
pattern between men with mild and severe ED.
Furthermore, the early and active patterns of nailfold ca-
pillary abnormalities were even less frequent in SSc men
with ED compared with those without ED (Table 1). With
respect to other vascular complications of SSc, there was
no association of ED with the presence of digital ulcers
and no significant association with signs of pulmonary ar-
terial hypertension. It should be noted, however, that none
of the 18 men without ED had a pulmonary arterial systolic
pressure540 mmHg, as estimated by echocardiography.
ED was associated with age (P= 0.002) and marginally
associated with skin involvement in terms of diffuse dis-
ease (P= 0.06) at univariate analysis. A multivariate
analysis confirmed the association of ED with age, but
failed to detect an association with nailfold patterns.
Numerically, more patients with diffuse disease had
severe ED and more patients with Scl70 also had severe
ED. However, we did not find a significant association
between these parameters and the presence or absence
of ED (P= 0.06 and 0.59, respectively).
We also analysed our data by grouping patients accord-
ing to the presence or absence of nailfold capillary
abnormalities. Sixty-nine men (88.5%) had nailfold capil-
lary abnormalities, among whom 54 (78.3%) suffered from
ED. Only nine patients had no nailfold capillary abnormal-
ities, as expected for an SSc population. The proportion
of ED was similar, however, in men without capillary
abnormalities (66.7%) in comparison with those with
abnormal capillaries (78.3%, P= 0.44). Furthermore, the
mean IIEF-5 score for men with and without any nailfold
capillary abnormality did not differ [15.7 (S.D. 6.2) vs 15.7
(S.D. 6.3)]. There was also a trend without significance
(P= 0.31) in the IIEF-5 scores for men with an early
(n= 12), active (n= 27) or late (n= 27) pattern (IIEF-5
scores of 17.9, 16.3 and 14.7, respectively).
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Nevertheless, and as determined previously [7], capillaro-
scopy abnormalities were associated with a higher
median EULAR DAS (P= 0.02), a lower diffusion capacity
of the lung for carbon monoxide (DLCO) (P= 0.001), a
lower forced vital capacity (P= 0.04) and a higher modified
Rodnan skin score (mRSS, P= 0.04).
Discussion
The main finding of our analysis is that nailfold capillaro-
scopy lacks a clinically useful association with the pres-
ence and severity of ED in SSc. Erection is a
neurovascular phenomenon under hormonal control. The
mechanisms of erection in healthy men include arterial
dilatation, smooth muscle relaxation and activation of
the corporeal veno-occlusive mechanism [5]. Although
our data are unable to exclude completely a true vascular
mechanism in the onset of SSc-associated ED, they do
not support involvement of a generalized small vessel dis-
ease in penile fibrosis and point towards the possibility of
veno-occlusive dysfunction or other mechanisms of ED
[14, 15]. The lack of association between diffuse disease,
Scl70 autoantibody positivity and the presence of ED has
also been shown before in a different subset of EUSTAR
study group men [4]. This finding suggests that ED may
not be linked to the overall severity of SSc.
As in any cross-sectional analysis, we cannot exclude
recruitment or ascertainment bias, although a previous
analysis demonstrated good intercentre reliability of nail-
fold capillaroscopy [16]. The IIEF-5 score does and cannot
evaluate men without intercourse and additional data on
impotence were not addressed in this analysis. The lack of
knowledge about the exact reasons for sexual abstinence
in the eight men that were excluded from our analysis due
to the lack of intercourse raises the possibility of a bias.
We have therefore also tested whether these eight men
would have altered our conclusions if they were attributed
to the group with severe ED. In this analysis (not shown),
there was still no significant association between ED and
capillaroscopy patterns, making this form of bias unlikely.
The fact that our dataset was able to replicate known
associations between capillaroscopy abnormalities and
pulmonary and cutaneous SSc complications [911] sug-
gests that the statistical power of our analysis was
adequate. The number of analysed male SSc patients in
this study is similar or even exceeds the number of popu-
lations found to be predictive of future organ manifest-
ations in other capillaroscopy studies [8, 9, 11, 17].
Despite the fact that a dynamic transition of microvascular
damage through different neurovascular compression
patterns has been demonstrated [18], the classification
of capillaroscopy findings into early, active and late pat-
terns may lack sensitivity in detecting and distinguishing
smaller degrees of vascular involvement. Therefore this
study should be replicated using quantitative scores
[19]. Capillaroscopy predominantly evaluates structural
impairment, thus further techniques that are able to
evaluate microvascular function, such as laser Doppler
imaging, might be helpful to clarify these questions.
Taken together, although nailfold capillaroscopy is
associated with some vascular organ complications,
such as digital ulcers, pulmonary arterial hypertension
and skin involvement [79], it appears that neither the
presence or absence of abnormal capillaroscopy findings
nor the subdivision into early, active and late patterns is a
useful tool in predicting coexistent ED.
Rheumatology key messages
. Nailfold capillary abnormalities in men with SSc are
associated with SSc organ complications.
. There is no association between abnormal capil-
laroscopy patterns and the presence or severity of
erectile dysfunction in men with SSc.
Funding support: This study was funded in part by
EULAR.
Disclosure statement: O.D. had consultancy relation-
ships and/or received research funding from Actelion,
Pfizer, Ergonex, BMS, Sanofi-Aventis, United BioSource,
Roche/Genentech, Medac, Biovitrium, Boehringer
Ingelheim Pharma, Novartis, 4D Science, Active Biotec
and Sinoxa in the area of potential treatments of sclero-
derma and its complications. U.M.L. is funded, in part, by
an unrestricted EULAR scientific grant. E.H. has received
honoraria and consultancy fees from Pfizer (<E10 000). All
other authors have declared no conflicts of interest.
References
1 Charles C, Clements P, Furst DE. Systemic sclerosis:
hypothesis-driven treatment strategies. Lancet 2006;367:
168391.
2 Cutolo M, Sulli A, Smith V. Assessing microvascular
changes in systemic sclerosis diagnosis and manage-
ment. Nat Rev Rheumatol 2010;6:57887.
3 Hong P, Pope JE, Ouimet JM et al. Erectile dysfunction
associated with scleroderma: a case-control study of men
with scleroderma and rheumatoid arthritis. J Rheumatol
2004;31:50813.
4 Foocharoen C, Tyndall A, Hachulla E et al. Erectile dys-
function is frequent in systemic sclerosis and associated
with severe disease: a study of the EULAR Scleroderma
Trial and Research group. Arthritis Res Ther 2012;14:R37.
5 Walker UA, Tyndall A, Ruszat R. Erectile dysfunction in
systemic sclerosis. Ann Rheum Dis 2009;68:10835.
6 Cutolo M, Sulli A, Pizzorni C et al. Nailfold videocapillaro-
scopy assessment of microvascular damage in systemic
sclerosis. J Rheumatol 2000;27:15560.
7 Herrick AL, Cutolo M. Clinical implications from capillaro-
scopic analysis in patients with Raynaud’s phenomenon
and systemic sclerosis. Arthritis Rheum 2010;62:
2595604.
8 Caramaschi P, Canestrini S, Martinelli N et al.
Scleroderma patients nailfold videocapillaroscopic pat-
terns are associated with disease subset and disease
severity. Rheumatology 2007;46:15669.
642 www.rheumatology.oxfordjournals.org
Andrea D. Keck et al.
9 Smith V, Decuman S, Sulli A et al. Do worsening sclero-
derma capillaroscopic patterns predict future severe
organ involvement? A pilot study. Ann Rheum Dis 2012;
71:16369.
10 Sebastiani M, Manfredi A, Vukatana G et al. Predictive role
of capillaroscopic skin ulcer risk index in systemic scler-
osis: a multicentre validation study. Ann Rheum Dis 2012;
71:6770.
11 Hofstee HM, Vonk NA, Voskuyl AE et al. Nailfold capillary
density is associated with the presence and severity of
pulmonary arterial hypertension in systemic sclerosis. Ann
Rheum Dis 2009;68:1915.
12 Walker UA, Tyndall A, Czirjak L et al. Clinical risk
assessment of organ manifestations in systemic
sclerosis: a report from the EULAR Scleroderma Trials
and Research group database. Ann Rheum Dis 2007;66:
75463.
13 Rosen RC, Cappelleri JC, Smith MD et al. Development
and evaluation of an abridged, 5-item version of the
International Index of Erectile Function (IIEF-5) as a diag-
nostic tool for erectile dysfunction. Int J Impot Res 1999;
11:31926.
14 Aversa A, Proietti M, Bruzziches R et al. The penile vas-
culature in systemic sclerosis: a duplex ultrasound study.
J Sex Med 2006;3:5548.
15 Nehra A, Hall SJ, Basile G et al. Systemic sclerosis and
impotence: a clinicopathological correlation. J Urol 1995;
153:11406.
16 Smith V, Pizzorni C, De KF et al. Reliability of the qualita-
tive and semiquantitative nailfold videocapillaroscopy as-
sessment in a systemic sclerosis cohort: a two-centre
study. Ann Rheum Dis 2010;69:10926.
17 Smith V, De KF, Pizzorni C et al. Nailfold capillaroscopy for
day-to-day clinical use: construction of a simple scoring
modality as a clinical prognostic index for digital trophic
lesions. Ann Rheum Dis 2011;70:1803.
18 Sulli A, Pizzorni C, Smith V et al. Timing of transition be-
tween capillaroscopic patterns in systemic sclerosis.
Arthritis Rheum 2012;64:8215.
19 Sebastiani M, Manfredi A, Colaci M et al. Capillaroscopic
skin ulcer risk index: a new prognostic tool for digital skin
ulcer development in systemic sclerosis patients. Arthritis
Rheum 2009;61:68894.
www.rheumatology.oxfordjournals.org 643
A EUSTAR group analysis
